SCHEMBL24313754

SCHEMBL24313754

CCOc1ccccc1[S+]([O-])NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 6/20 0.36
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 5/20 0.35
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CYP2C9 P11712 1/20 0.34
ADRA2B P18089 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34
CYP2C19 P33261 1/20 0.34
DRD3 P35462 1/20 0.34
HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313966 0.93 UGCG (0.35) ALDH1A1LMNAKCNH2GAAMRGPRX1
SCHEMBL24314235 0.92 KCNH2 (0.36) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL24313660 0.92 KCNH2 (0.35) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24313761 0.89 MEN1 (0.32) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24313750 0.89 KAT2B (0.33) ALDH1A1KCNH2KDM4EHTTHPGD
SCHEMBL24313661 0.89 KCNK3 (0.36) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24314229 0.89 PTGS2 (0.35) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24314298 0.89 MEN1 (0.33) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24314200 0.88 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL24314220 0.88 KDM4E (0.33) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed